These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4311979)

  • 1. [Factors participating in the formation of Cl. perfringens BP6K alpha-toxin in media of determined chemical composition. I. The mechanism of the stimulating effect of an excess of arginine on toxin formation].
    Mekhedov LN
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Aug; 46(8):117-24. PubMed ID: 4311979
    [No Abstract]   [Full Text] [Related]  

  • 2. [An electron microscopic study of Cl. perfringens in the process of toxin formation].
    Kushnarev VM; Smirnova TA; Mikhaĭlova IM
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):19-24. PubMed ID: 4308710
    [No Abstract]   [Full Text] [Related]  

  • 3. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of iron on the growth and toxin formation of Clostridium perfringens type A cultures].
    Artemenko VD; Kuznetsova GI; Nenashev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):20-4. PubMed ID: 6098107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medium for toxin production by Clostridium perfringens in continuous culture.
    Chou G
    Appl Microbiol; 1971 May; 21(5):794-8. PubMed ID: 4324884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxin formation by Cl. perfringens type E].
    Zemlianitskaia EP; Matveev KI; Tsurikov FF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of peptidic groups isolated from enzymic casein hydrolysate on growth and toxinogenesis of Clostridium welchii (perfringens).
    Nekvasilová K; Sídlo J; Háza J
    J Gen Microbiol; 1970 Jul; 62(1):3-16. PubMed ID: 4321096
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the toxigenic properties of a mixture of the S- and R-forms of Clostridium perfringens 28 (BP6K)].
    Kalinichenko NF; Biriukova SV; Starobinets ZG; Podgornaia LG
    Mikrobiol Zh; 1976; 38(2):197-200. PubMed ID: 181662
    [No Abstract]   [Full Text] [Related]  

  • 9. [Obtention of Cl. perfringens toxin on a culture medium of casein pancreatic hydrolysate].
    SAMSONOVA VS
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Dec; 33():138-40. PubMed ID: 13976160
    [No Abstract]   [Full Text] [Related]  

  • 10. Avirulent Clostridium perfringens strains obtained by euflavine treatment.
    Paquette G; Fredette V
    J Bacteriol; 1967 Nov; 94(5):1437-42. PubMed ID: 4293665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxin production by Cl. perfringens of types A and D on synthetic media].
    Bychenko BD; Ivanova LG
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Jan; 45(1):84-9. PubMed ID: 4298565
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of protease production of various bacteria by ammonium salts: its effect on toxin production and virulence.
    Liu PV; Hsieh HC
    J Bacteriol; 1969 Aug; 99(2):406-13. PubMed ID: 4309097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extraction of dry concentrated toxin from Cl. perfringens type E].
    Zemlianitskaia EP; Samsonova VS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):94-8. PubMed ID: 4308596
    [No Abstract]   [Full Text] [Related]  

  • 14. [Patterns in the development of deep cultures of Cl. perfringens].
    Akhundova KA; Nenashev VP; Artemenko VD
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):29-34. PubMed ID: 4324430
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a synthetic medium for cultivating pathogenic anaerobes].
    Ivanova LG; Sergeeva TI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):40-3. PubMed ID: 164749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ornithine transcarbamylase in Clostridium perfingens].
    Dolgikh MS; Blagoveshchenskiĭ VA
    Vopr Med Khim; 1975; 21(2):143-7. PubMed ID: 237365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of changes in the oxidation-reduction potential (rH2) and morphology of Cl. perfringens cultures in the course of toxin formation on semisynthetic culture medium].
    Samsonova VS; Volkova ZM; Shamraeva SA; Tsurikov FF; Solov'ev NN
    Zh Mikrobiol Epidemiol Immunobiol; 1965 Apr; 42(4):137-41. PubMed ID: 4287673
    [No Abstract]   [Full Text] [Related]  

  • 18. [A study of the arginine desimidase system in toxigenic and weak-toxigenic strains of Clostridium perfringens type A].
    Blagoveshchenskiĭ VA; Dolgikh MS; Borishpolets ZI
    Dokl Akad Nauk SSSR; 1969; 188(2):458-61. PubMed ID: 4315663
    [No Abstract]   [Full Text] [Related]  

  • 19. [CL. PERFRINGENS TOXIN PRODUCTION. I. MORPHOLOGICAL STUDIES AND TOXIN PRODUCTION BY CL. PERFRINGENS ON SEMI-SYNTHETIC CULTURE MEDIA].
    VOLKOVA ZM; VYGODCHIKOV GV; KORN MIa; GILGUT EA; SAMSONOVA VS; SOLOVEV NN
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Dec; 41():43-8. PubMed ID: 14333942
    [No Abstract]   [Full Text] [Related]  

  • 20. The participation of ornithine and citrulline in the regulation of arginine metabolism in Saccharomyces cerevisiae.
    Ramos F; Thuriaux P; Wiame JM; Bechet J
    Eur J Biochem; 1970 Jan; 12(1):40-7. PubMed ID: 5434282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.